Literature DB >> 25086109

Are Gujarati Asian Indians 'older' for their 'vascular age' as compared to their 'Chronological age'?

K H Sharma1, S Sahoo2, K H Shah2, A K Patel2, N D Jadhav2, M M Parmar2, K H Patel2.   

Abstract

BACKGROUND: South Asians are known to carry higher burden of cardiovascular diseases when compared with their Caucasian counterparts. AIM: This study was designed to evaluate whether vascular age is advanced for Gujarati Asian Indians as matched to their chronological age in apparently healthy, asymptomatic population. We have also assessed the contributing risk factors for premature vascular ageing.
DESIGN: It was cross-sectional study of 2483 individuals of Gujarat state in Western India having no past or present history of major illness including cardiovascular diseases.
METHOD: The vascular age of the population was calculated using Framingham vascular age calculator. A relationship between risk factor prevalence and vascular ageing was evaluated using univariate analysis of variance.
RESULTS: The mean chronological age of the study population was 46.8 (±10.35) years whereas mean vascular age was 53.34 (±16.05) years, and the difference (6.54±9.5) between both was statistically significant (P < 0.0001). Contributory risk factors for advanced vascular age apart from chronological age (75.4%) and male gender (66.2%) were the presence of dyslipidemia (60.4%) hypertension (57.34%) and increased waist circumference (WC) (male 39.7%, female 29%). Results of regression analysis showed that vascular age progression was highly associated with blood pressure (19.9, 95% CI: 14.34-27.63), followed by smoking (15.23, 95% CI: 8.4-27.59), and blood sugar (12.97, 95% CI: 3.48-48.25).
CONCLUSION: The Gujarati Asian Indians are subjected to premature vascular ageing and henceforth routine screening for vascular age and risk factors prevalence is strongly advocated in this ethnic group.
© The Author 2014. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25086109     DOI: 10.1093/qjmed/hcu158

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  5 in total

1.  Do circulating blood cell types correlate with modifiable risk factors and outcomes in patients with acute coronary syndrome (ACS)?

Authors:  Kamal H Sharma; Komal H Shah; Iva Patel; Alap K Patel; Subhash Chaudhari
Journal:  Indian Heart J       Date:  2015-08-06

2.  Aortic pulse wave velocity in individuals of Asian and African ancestry: the HELISUR study.

Authors:  Frederieke S Diemer; Se-Sergio M Baldew; Yentl C Haan; Fares A Karamat; Glenn P Oehlers; Gert A van Montfrans; Bert-Jan H van den Born; Ron J G Peters; Lenny M W Nahar-Van Venrooij; Lizzy M Brewster
Journal:  J Hum Hypertens       Date:  2018-12-19       Impact factor: 3.012

3.  Ultrasound-based stroke/cardiovascular risk stratification using Framingham Risk Score and ASCVD Risk Score based on "Integrated Vascular Age" instead of "Chronological Age": a multi-ethnic study of Asian Indian, Caucasian, and Japanese cohorts.

Authors:  Ankush Jamthikar; Deep Gupta; Elisa Cuadrado-Godia; Anudeep Puvvula; Narendra N Khanna; Luca Saba; Klaudija Viskovic; Sophie Mavrogeni; Monika Turk; John R Laird; Gyan Pareek; Martin Miner; Petros P Sfikakis; Athanasios Protogerou; George D Kitas; Chithra Shankar; Andrew Nicolaides; Vijay Viswanathan; Aditya Sharma; Jasjit S Suri
Journal:  Cardiovasc Diagn Ther       Date:  2020-08

4.  Age and Sex Specific Reference Intervals for Modifiable Risk Factors of Cardiovascular Diseases for Gujarati Asian Indians.

Authors:  Sibasis Sahoo; Komal H Shah; Ashwati R Konat; Kamal H Sharma; Payal Tripathi
Journal:  Int J Chronic Dis       Date:  2015-12-28

5.  Cardiovascular Disease Risk Assessment in the United States and Low- and Middle-Income Countries Using Predicted Heart/Vascular Age.

Authors:  Duke Appiah; Benjamin D Capistrant
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.